Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / GLAXF - Gilead's Achilles' Heel - HIV Franchise In Serious Jeopardy


GLAXF - Gilead's Achilles' Heel - HIV Franchise In Serious Jeopardy

Source (Shutterstock/Liya Graphics)

Introduction

Gilead Sciences (GILD) was positioned to be the poster child of Trump's plan to eradicate HIV, as outlined in my previous article. Like almost all outbreaks including the Wuhan coronavirus, the only effective way to completely or almost eradicate HIV is to reduce the number of new infections. Currently for HIV, the only FDA approved pre-exposure prophylaxis (PrEP) drugs are Gilead's Truvada and Descovy, making Gilead at the heart of Trump's HIV plan, which was unveiled at the 2019 State of the Union Address. Gilead's PrEP drugs

Read more ...

Stock Information

Company Name: GlaxoSmithKline Plc
Stock Symbol: GLAXF
Market: OTC
Website: gsk.com

Menu

GLAXF GLAXF Quote GLAXF Short GLAXF News GLAXF Articles GLAXF Message Board
Get GLAXF Alerts

News, Short Squeeze, Breakout and More Instantly...